Page results
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
UCLH has recruited the first patient to a global trial of an investigational medication for adults with Huntington’s Disease (HD).
-
Photographs captured during the Black History Month screening on 24th October 2024.
-
Following the successful premiere at Everyman Cinema, Muswell Hill, SICKLE, the groundbreaking documentary on sickle cell disorder, continued its impactful journey with a screening at Ritzy Picture House in Brixton on Thursday 24 October. Held in celebration of Black History Month, the event aimed to raise awareness and educate both healthcare professionals and the public about the realities of living with sickle cell disorder.
-
More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
Professor Karl Peggs was appointed to the Board in August 2024 as the director of research and director of the National Institute for Health and Care Research (NIHR) UCLH Biomedical Research Centre (BRC).
-
The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.
-
Two directors have joined the UCLH Board – Liz O’Hara, director of workforce and Laura Churchward, director of strategy.
-
Details of the charity and voluntary sector services in Islington and surrounding areas.
File results
-
FOI/2022/0769 - Non-disclosure agreement to resolve sexual harassment cases
-
FOI/2022/0778 - Phone calls to 09020 44 24 11 from NHS Trust
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0789 - Agencies (including off framework) used to supply locum agency doctors
-
FOI/2022/0795 - Mobile software (communications, chat, photo) used by the Trust
-
FOI/2022/0799 - Services outsourced to third parties for Finance, Payroll, Procurement
-
FOI/2022/0800 - Day unit/ outpatient unit for haematology patients
-
FOI/2023/0005 - Endoscopy numbers - inflammatory bowel disease
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide